Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Leitner

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Methods in Cell Biology|February 7, 2025
Gauging antigen recognition by human primary T-cells featuring orthotopically exchanged TCRs of choiceVanessa Mühlgrabner, Angelika Plach, Johannes Holler, et al.
Frontiers in Immunology|February 18, 2025
Cyclophilin-CD147 interaction enables SARS-CoV-2 infection of human monocytes and their activation via Toll-like receptors 7 and 8Gabor Tajti, Laura Gebetsberger, Gregor Pamlitschka, et al.
Oncotarget|May 1, 2018
A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategiesSandra Rosskopf, Judith Leitner, Wolfgang Paster, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2018
Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell PlatformJulian Rydzek, Thomas Nerreter, Haiyong Peng, et al.
Clinical Immunology (Orlando, Fla.)|March 19, 2011
Costimulatory signals potently modulate the T cell inhibitory capacity of the therapeutic CD11a antibody EfalizumabWerner M Kuschei, Judith Leitner, Otto Majdic, et al.
European Journal of Immunology|December 21, 2020
Differentiation and activation of human CD4 T cells is associated with a gradual loss of myelin and lymphocyte proteinJudith Leitner, Kodchakorn Mahasongkram, Philipp Schatzlmaier, et al.
Frontiers in Immunology|June 8, 2017
PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic CellsCarmen Stecher, Claire Battin, Judith Leitner, et al.
Immunology|May 21, 2022
NKG2A-checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA-EClaire Battin, Gabriel Kaufmann, Judith Leitner, et al.
Frontiers in Immunology|August 17, 2019
Development of a Human Cytomegalovirus (HCMV)-Based Therapeutic Cancer Vaccine Uncovers a Previously Unsuspected Viral Block of MHC Class I Antigen PresentationMohammed O Abdelaziz, Sophia Ossmann, Andreas M Kaufmann, et al.
Heliyon|August 3, 2023
Human intestine and placenta exhibit tissue-specific expression of RAGE isoformsKatharina Schwertner, Katharina Gelles, Judith Leitner, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Methods in Cell Biology|February 7, 2025
Gauging antigen recognition by human primary T-cells featuring orthotopically exchanged TCRs of choiceVanessa Mühlgrabner, Angelika Plach, Johannes Holler, et al.
Frontiers in Immunology|February 18, 2025
Cyclophilin-CD147 interaction enables SARS-CoV-2 infection of human monocytes and their activation via Toll-like receptors 7 and 8Gabor Tajti, Laura Gebetsberger, Gregor Pamlitschka, et al.
Oncotarget|May 1, 2018
A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategiesSandra Rosskopf, Judith Leitner, Wolfgang Paster, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2018
Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell PlatformJulian Rydzek, Thomas Nerreter, Haiyong Peng, et al.
Clinical Immunology (Orlando, Fla.)|March 19, 2011
Costimulatory signals potently modulate the T cell inhibitory capacity of the therapeutic CD11a antibody EfalizumabWerner M Kuschei, Judith Leitner, Otto Majdic, et al.
European Journal of Immunology|December 21, 2020
Differentiation and activation of human CD4 T cells is associated with a gradual loss of myelin and lymphocyte proteinJudith Leitner, Kodchakorn Mahasongkram, Philipp Schatzlmaier, et al.
Frontiers in Immunology|June 8, 2017
PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic CellsCarmen Stecher, Claire Battin, Judith Leitner, et al.
Immunology|May 21, 2022
NKG2A-checkpoint inhibition and its blockade critically depends on peptides presented by its ligand HLA-EClaire Battin, Gabriel Kaufmann, Judith Leitner, et al.
Frontiers in Immunology|August 17, 2019
Development of a Human Cytomegalovirus (HCMV)-Based Therapeutic Cancer Vaccine Uncovers a Previously Unsuspected Viral Block of MHC Class I Antigen PresentationMohammed O Abdelaziz, Sophia Ossmann, Andreas M Kaufmann, et al.
Heliyon|August 3, 2023
Human intestine and placenta exhibit tissue-specific expression of RAGE isoformsKatharina Schwertner, Katharina Gelles, Judith Leitner, et al.
Pageof 8